# | Title | Journal | Year | Citations |
---|
1 | Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension | New England Journal of Medicine | 2005 | 2,237 |
2 | Clinical classification of pulmonary hypertension | Journal of the American College of Cardiology | 2004 | 1,542 |
3 | Diagnosis and Assessment of Pulmonary Arterial Hypertension | Journal of the American College of Cardiology | 2009 | 984 |
4 | Ambrisentan for the Treatment of Pulmonary Arterial Hypertension | Circulation | 2008 | 967 |
5 | Tadalafil Therapy for Pulmonary Arterial Hypertension | Circulation | 2009 | 956 |
6 | A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) | European Heart Journal | 2014 | 848 |
7 | Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial | Lancet, The | 2008 | 844 |
8 | Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial | Journal of the American College of Cardiology | 2002 | 584 |
9 | A meta-analysis of randomized controlled trials in pulmonary arterial hypertension | European Heart Journal | 2008 | 553 |
10 | Guideline of transthyretin-related hereditary amyloidosis for clinicians | Orphanet Journal of Rare Diseases | 2013 | 525 |
11 | Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers | Journal of the American College of Cardiology | 2006 | 498 |
12 | Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension | Journal of the American College of Cardiology | 2009 | 463 |
13 | Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan | Journal of the American College of Cardiology | 2006 | 462 |
14 | Right heart thrombi in pulmonary embolism | Journal of the American College of Cardiology | 2003 | 445 |
15 | The endothelin system in pulmonary arterial hypertension | Cardiovascular Research | 2004 | 412 |
16 | Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers | Journal of the American College of Cardiology | 2005 | 375 |
17 | Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension | Journal of the American College of Cardiology | 2009 | 353 |
18 | Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) | European Heart Journal | 2014 | 347 |
19 | Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events | Journal of Cardiovascular Electrophysiology | 2009 | 341 |
20 | Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro | BMC Developmental Biology | 2007 | 337 |
21 | Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension | Journal of the American College of Cardiology | 2003 | 334 |
22 | BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis | Lancet Respiratory Medicine,the | 2016 | 307 |
23 | Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis | BMJ: British Medical Journal | 2008 | 270 |
24 | Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry | American Journal of Medicine | 2015 | 242 |
25 | Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension | Chest | 2011 | 237 |
26 | Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease | Chest | 2004 | 232 |
27 | Left Superior Vena Cava Persistence in Patients Undergoing Pacemaker or Cardioverter-Defibrillator Implantation | Chest | 2001 | 224 |
28 | End Points and Clinical Trial Design in Pulmonary Arterial Hypertension | Journal of the American College of Cardiology | 2009 | 209 |
29 | Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension | Journal of the American College of Cardiology | 2004 | 206 |
30 | Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry) | European Heart Journal | 2014 | 204 |
31 | Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy | Journal of the American College of Cardiology | 2005 | 199 |
32 | Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction | Heart | 2007 | 198 |
33 | Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring | Stroke | 2011 | 176 |
34 | Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells | Basic Research in Cardiology | 2005 | 174 |
35 | Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy | American Heart Journal | 2006 | 169 |
36 | Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation | Europace | 2015 | 164 |
37 | Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy | Stroke | 2003 | 158 |
38 | Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses | European Heart Journal | 2010 | 157 |
39 | Endothelin receptor antagonists in pulmonary arterial hypertension | Journal of the American College of Cardiology | 2004 | 153 |
40 | Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome | Drugs | 2008 | 153 |
41 | Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts | Journal of Biological Chemistry | 2007 | 152 |
42 | Bicuspid Aortic Valve Stenosis | JACC: Cardiovascular Interventions | 2016 | 147 |
43 | ‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey | American Journal of Medicine | 2014 | 144 |
44 | Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance | Heart | 2005 | 142 |
45 | Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry | Europace | 2015 | 128 |
46 | Tadalafil for the Treatment of Pulmonary Arterial Hypertension | Journal of the American College of Cardiology | 2012 | 124 |
47 | Prostanoids for Pulmonary Arterial Hypertension | Treatments in Respiratory Medicine | 2003 | 123 |
48 | Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors | Journal of Clinical Pharmacology | 1993 | 122 |
49 | Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry | Europace | 2018 | 118 |
50 | Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults | Journal of the American College of Cardiology | 2004 | 115 |